/

Repertoire Immune Medicines

Developing T cell-targeted therapies for cancer and autoimmune diseases.

BiotechnologyDrug Discovery repertoire.com ↗

Company facts

Founded: 2019
Employees: 90
Headquarters: United States
Type: Private
Funding: Series B · $189M · 2021